Omeros has filed an investigational new drug application (IND) with the FDA for OMS824, the compound from its phosphodiesterase 10 (PDE10) program for schizophrenia and other cognitive disorders. OMS824 targets and inhibits an enzyme ...
Tags: new drug application, FDA, OMS824
Soon you could have access to secret information just by waving your hand. New digital signage allows you to decode invisible images by quickly moving your fingers in front of the screen. The system, developed by Hirotsugu Yamamoto and ...
Tags: LED panel, invisible images
Neurotez has received US patent covering hormone Leptin for treating Alzheimer's disease (AD) resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid ...
Tags: Leptin, Alzheimer's disease, endogenous pluripotent hormone
The FDA has approved Genzyme, a Sanofi company, Aubagio (teriflunomide) as a new once-daily, oral treatment indicated for relapsing forms of multiple sclerosis (MS). Aubagio, an immunomodulator with anti-inflammatory properties, has shown ...
Tags: Aubagio, teriflunomide, new once-daily, oral treatment
Perrigo Company has received a final Approval for Registration letter permitting the company to sell generic temozolomide in Australia. The letter also states that bioequivalence was met between the brand product, Temodar, and the ...
Alan Offenberg has been named chief executive officer by the Compass Diversified Holdings board and will remain on the company's board of directors. Compass is the parent of Fox and CamelBak. Offenberg is a founding partner of Compass ...
Tags: Fox, CamelBak, Compass Group
Novartis has obtained the US Food and Drug Administration (FDA) approval for a new 13.3 mg/24 h dosage strength of its Exelon Patch (rivastigmine transdermal system), designed to treat patients with mild to moderate Alzheimer's disease. ...
Tags: Alzheimer's disease, Novartis Pharmaceuticals, Exelon Patch
Chronix Biomedical has opened a fully operational sequencing laboratory in Brookings, South Dakota, US, to expand its commercial capabilities. Chronix has opened the laboratory in association with the First Bank & Trust of Brookings, ...
Competitor Group Inc. confirmed Monday that it has been sold to Calera Capital, as reported by several news sources including BRAIN last week. In a press release, Calera said Scott Dickey, president and chief executive officer, and Steve ...
Tags: Competitor Group, strategy of developing, New ownership
LAGUNA HILLS, CA (BRAIN) — Nine out of 10 dentists would likely approve. Brian Riley and Kyle Jansen stopped in at BRAIN's offices this week on the final stretch of their "Save Your Teeth Tour," a 40-day road trip that stopped by ...
Tags: road trip, Slidepad brakes, bike models
Editor's note: The following story first ran in the November issue of Bicycle Retailer & Industry News. It was published before Interbike's decision to allow consumers to attend the show and has been edited slightly as a result. LAS ...
Tags: Bicycle Retailer, Industry News, Interbike
Nestlé Health Science has purchased an undisclosed stake in Accera, a privately-held US-based company that is involved in the development and the commercialization of medical foods for neurodegenerative disorders such as Alzheimer's ...
China is a country with an ancient civilization, and the modern Chinese standards of beauty often mimic those from thousands of years ago. Garment The ancients had their own attitude towards beauty and fashion. "Beauties Wearing ...
More than 40 percent of independent bicycle dealers report stronger Black Friday sales this year than in 2011, according to research firm Leisure Trends Group. Leisure Trends broke out the IBD data for BRAIN from a broader survey of ...
Tags: bicycle, IBD data, Black Friday, sporting goods, footwear
Falconhead Capital, the owner of Competitor Group Inc., has sold the company to another venture capital group, Calera Capital Partners. CGI publishes Velo and Triathlete magazines and their associated websites. The company also owns the ...
Tags: Competitor Group, company news, Reports Competitor Group